Welcome to episode 34 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and me, Trevor Abes, each deliver a 2.5-minute stock profile related to recent news stories with investment implications. This week, we’re talking about a pair of quantum computing stocks in line for some well-deserved attention following reports of the US government’s intention to fund quantum-related companies to bolster national security.
Here are Jon’s show notes for episode 34:
- Quantum leap: D-Wave surges as U.S. eyes equity stakes in tech firms.
- Jon’s quantum computing stock is D-Wave Quantum (NYSE:QBTS), the world’s first commercial provider of quantum computers.
- At the time of writing, D-Wave Quantum stock last traded at US$32.65, having gained 2,620.83 per cent year-over-year.
Here are Trevor’s show notes:
- Quantum eMotion takes on battery energy storage market.
- Trevor’s quantum computing stock is Quantum eMotion (TSXV:QNC), a developer of cryptographic solutions based on its proprietary quantum random number generator technology.
- At the time of writing, Quantum eMotion stock last traded at C$3.51, having gained 2,825 per cent year-over-year.
Here’s a list of recent episodes:
- Episode 28: Flow-through mining plays.
- Episode 29: Green infrastructure stocks.
- Episode 30: Underrated real estate stocks.
- Episode 31: Promising gaming stocks.
- Episode 32: Government-backed mining stocks.
- Episode 33: 10-bagger stocks.
Thanks for listening!
The 5-Minute Investor is on Spotify, YouTube, iHeartRadio, Podbean, Stockhouse or wherever finer podcasts are found.
Join the discussion: Find out what investors are saying about The 5-Minute Investor Podcast and these quantum computing stocks on the D-Wave Quantum Inc. and Quantum eMotion Corp. Bullboards, and make sure to explore the rest of Stockhouse’s stock forums and message boards.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein.
For full disclaimer information, please click here.